EKSO Projected Dividend Yield

Com Par $0.001/Ekso Bionics Holdings Inc ( NASDAQ : EKSO )

Ekso Bionics Holdings designs, develops, and markets exoskeleton products. Co.'s products for rehabilitation applications include: EksoNR, which is a wearable bionic exoskeleton that allows hospitals and other rehabilitation providers to deliver over ground gait therapy and ambulation assistance; Ekso Indego Therapy, which can be custom-sized and provided to patients allowing for swift donning; and Ekso Indego Personal, which enables people with mobility impairments the opportunity to walk independently. Co.'s primary product for able-bodied industrial applications is EVO, which elevates and supports a worker's arms to assist them with tasks ranging from chest height to overhead.

20 YEAR PERFORMANCE RESULTS